Promisingly, the determined relationship between the local immunological TME remodeling and GPR81-mediated metabolic regulation in BC in our investigation is able to provide a feasible approach to stratify BC patients to maximize the efficacy of ICB therapy. Here, HCAR1 is linked to breast cancer.